Page 117 - 《中国药房》2023年20期

注了单核苷酸多态性，纳入的样本量较少，不能完全解 Genomewide association between GLCCI1 and response
释 ICSs 应答的个体差异，且 ACO 患者经 ICSs 治疗的临 to glucocorticoid therapy in asthma[J]. N Engl J Med，
床获益机制还需进一步研究。（3）基于药物的易获得性， 2011，365（13）：1173-1183.
本研究以沙美特罗替卡松代表ICSs，所得结果是否可外 [ 9 ] RIJAVEC M，ŽAVBI M，LOPERT A，et al. GLCCI1 poly‐
推到其他ICSs暂不清楚。（4）支气管扩张剂联合ICSs治 morphism rs37973 and response to treatment of asthma
with inhaled corticosteroids[J]. J Investig Allergol Clin
疗可能会影响ICSs的疗效。在后续研究中，本课题组将
Immunol，2018，28（3）：165-171.
进一步完善 GLCCI1 基因 rs37973 位点单倍型研究和体
[10] LEI Y，GAO Y P，CHEN J K，et al. GLCCI1 rs37973：a
外荧光素酶报告基因试验，并评价突变位点对 GLCCI1
potential genetic predictor of therapeutic response to
基因表达及炎症细胞因子凋亡的影响，以探索不同基因
inhaled corticosteroids in Chinese chronic obstructive
型对ICSs应答差异的机制。 pulmonary disease patients[J]. Sci Rep，2017，7：42552.
综上所述，GLCCI1基因rs37973位点GG型ACO患 [11] HARDIN M，CHO M，MCDONALD M L，et al. The clini‐
者对ICSs的治疗反应较其他基因型差，其中吸烟史＞20 cal and genetic features of COPD-asthma overlap syn‐
包年的患者反应更差。 drome[J]. Eur Respir J，2014，44（2）：341-350.
参考文献 [12] MILLER M R，HANKINSON J，BRUSASCO V，et al.
[ 1 ] GBD Chronic Respiratory Diseases Collaborators. Global Standardisation of spirometry[J]. Eur Respir J，2005，26
burden of chronic respiratory diseases and risk factors， （2）：319-338.
1990-2019：an update from the Global Burden of Disease [13] CGS Report. Terminology，definitions，and classification
Study 2019[J]. EClinicalMedicine，2023，59：101936. of chronic pulmonary emphysema and related conditions
[ 2 ] Global Initiative for Asthma，Global Initiative for Chronic [J]. Thorax，1959，14（4）：286-299．
Obstructive Lung Disease. Diagnosis of diseases of chronic [14] POSTMA D S，WEISS S T，VAN DEN BERGE M，et al.
airflow limitation：asthma COPD and asthma-COPD over‐ Revisiting the Dutch hypothesis[J]. J Allergy Clin Immu‐
lap syndrome（ACOS）[EB/OL]. [2022-12-23]. https：// nol，2015，136（3）：521-529.
goldcopd. org/wp-content/uploads/2016/04/GOLD_ACOS_ [15] MIRAVITLLES M. Asthma-COPD overlap（ACO）PRO-
2015.pdf. CON debate. ACO：call me by my name[J]. COPD，2020，
[ 3 ] WOODRUFF P G，VAN DEN BERGE M，BOUCHER R 17（5）：471-473.
C，et al. American Thoracic Society/national heart，lung， [16] CHAPMAN M S，QU N，PASCOE S，et al. Isolation of
and blood institute asthma-chronic obstructive pulmonary differentially expressed sequence tags from steroid-
disease overlap workshop report[J]. Am J Respir Crit Care responsive cells using mRNA differential display[J]. Mol
Med，2017，196（3）：375-381. Cell Endocrinol，1995，108（1/2）：R1-R7.
[ 4 ] VAZ FRAGOSO C A，MURPHY T E，AGOGO G O，et [17] IZUHARA Y，MATSUMOTO H，KANEMITSU Y，et al.
al. Asthma-COPD overlap syndrome in the US：a prospec‐ GLCCI1 variant accelerates pulmonary function decline in
tive population-based analysis of patient-reported out‐ patients with asthma receiving inhaled corticosteroids[J].
comes and health care utilization[J]. Int J Chron Obstruct Allergy，2014，69（5）：668-673.
Pulmon Dis，2017，12：517-527. [18] POSTMA D S，KERKHOF M，BOEZEN H M，et al.
[ 5 ] HIKICHI M，HASHIMOTO S，GON Y. Asthma and Asthma and chronic obstructive pulmonary disease：com‐
COPD overlap pathophysiology of ACO[J]. Allergol Int， mon genes，common environments?[J]. Am J Respir Crit
2018，67（2）：179-186. Care Med，2011，183（12）：1588-1594.
[ 6 ] SIN D D，MIRAVITLLES M，MANNINO D M，et al. [19] ANTHONISEN N R，CONNETT J E，MURRAY R P.
What is asthma-COPD overlap syndrome? Towards a con‐ Smoking and lung function of lung health study partici‐
sensus definition from a round table discussion[J]. Eur pants after 11 years[J]. Am J Respir Crit Care Med，2002，
Respir J，2016，48（3）：664-673. 166（5）：675-679.
[ 7 ] JANG A S，LEE J H，PARK S W，et al. Factors influen- [20] MIRAVITLLES M. Diagnosis of asthma-COPD overlap：
cing the responsiveness to inhaled glucocorticoids of the five commandments[J]. Eur Respir J，2017，49（5）：
patients with moderate-to-severe asthma[J]. Chest，2005， 1700506.
128（3）：1140-1145. （收稿日期：2023-07-10 修回日期：2023-09-22）
[ 8 ] TANTISIRA K G，LASKY-SU J，HARADA M，et al. （编辑：陈 宏）

中国药房 2023年第34卷第20期 China Pharmacy 2023 Vol. 34 No. 20 · 2539 ·